Molecule intelOpportunity: Moderate0

Human Albumin

14 brands · 10 companies · product forms

Opportunity snapshot

Launch attractiveness
38
Market saturation
26
Price room
100
Regulatory risk
0
14
brands
10
companies
Rs 17,456.25
median price
13
price points
5.04x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 14%

Price room

Across observed sources and strengths
CheapestRs 7,463.86
MedianRs 17,456.25
Most expensiveRs 37,603.38
Spread5.04×
Sources: DRAP-official, DVAGO

max/min price ratio 5.04x across 13 trusted points (Rs 7463.86-37603.38). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Human Albumin — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(74) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

10 canonical companies and 14 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 5.04x across 13 trusted points (Rs 7463.86-37603.38). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.